Kidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
JACC. Heart failureMar 2026
GLP-1 Research Tracker
Every clinical trial and published study on semaglutide, tirzepatide, and next-generation GLP-1 medications — curated with plain-language summaries.
234 studies tracked·6 compounds covered·Updated Jul 2026
Joint TOS/OMA/OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach.
semaglutidetirzepatideliraglutide
Obesity (Silver Spring, Md.)Mar 2026
Semaglutide use in a patient with a long-term ileostomy: A case report highlighting clinical risks and evidence gaps.
semaglutideliraglutide
Journal of the American Pharmacists Association : JAPhAMar 2026
Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly.
semaglutide
Diabetes careMar 2026
Clinical Efficacy of a Flavo-Proxylane Topical Regimen Pre- and Post-ultrasound Procedure for Subjects Undergoing Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Therapy.
Dermatology and therapyMar 2026
Effects of Glucagon-Like Peptide-1 Receptor Agonists (Mono and Combination Therapy) on Energy Expenditure: A Scoping Review.
semaglutideliraglutide
Obesity reviews : an official journal of the International Association for the Study of ObesityMar 2026
Semaglutide Reduces Murine Blood Pressure Through the Vascular Smooth Muscle GLP-1 Receptor.
semaglutide
JCI insightMar 2026
Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis.
semaglutideliraglutide
JAMA internal medicineMar 2026
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial.
semaglutide
Nature medicineMar 2026
Digital Microsteps as Scalable Adjuncts for Adults Using GLP-1 Receptor Agonists: A Randomized Clinical Trial.
JAMA network openMar 2026
Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders: Empirical Review and Clinical Guidance.
The Psychiatric clinics of North AmericaMar 2026
[Obesity: novel pharmacological treatments].
semaglutidetirzepatideliraglutide
Deutsche medizinische Wochenschrift (1946)Mar 2026
GLP-1 receptor agonists and obstructive lung disease: Beyond metabolic control to respiratory outcomes.
Metabolism openMar 2026
The Effect of GLP-1 Receptor Agonists on Alanine Aminotransferase and Other Metabolic Parameters in Youths with Obesity: A Systematic Review and Meta-Analysis.
semaglutideliraglutide
Childhood obesity (Print)Mar 2026
Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials.
survodutideretatrutide
Endocrinology, diabetes & metabolismMar 2026
Beyond weight loss: Effect of GLP-1 receptor agonist therapy on the urological health.
tirzepatide
Urology case reportsMar 2026
Real-world 6-month persistence, adherence, and effectiveness of GLP-1 medications for overweight and obesity in a Medicaid population.
semaglutidetirzepatide
Journal of managed care & specialty pharmacyMar 2026
Trends in 1-year persistence and adherence among initiators of high-potency, weight loss-indicated glucagon-like peptide 1 receptor agonists.
semaglutidetirzepatide
Journal of managed care & specialty pharmacyMar 2026
A Systematic Review and Meta-Analysis of Semaglutide Effects on Adipose Tissue and Emerging Effects on Brain and Cognition.
semaglutide
Obesity reviews : an official journal of the International Association for the Study of ObesityMar 2026
Weight regain after bariatric surgery: A framework for management.
semaglutidetirzepatideliraglutide
JAAPA : official journal of the American Academy of Physician AssistantsMar 2026
Get Weekly Research Updates
New clinical trials, study results, and plain-language summaries delivered to your inbox.
Free weekly newsletter · No spam, unsubscribe anytime